Amphetamine
Back to searchMolecule Structure
Scientific Name
Amphetamine
Description of the Drug
Amphetamine is a CNS stimulant and sympathomimetic agent indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00182
http://www.drugbank.ca/drugs/DB00182
Brand Name(s)
Adzenys er, Adzenys xr-odt, Dyanavel xr
Company Owner(s)
Alkem Laboratories Ltd, Takeda Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Inc, Nesher Pharmaceuticals Usa Llc, Elite Laboratories Inc, Rhodes Pharmaceuticals Lp, Granules Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Uspharma Windlas Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL238 |
| Norepinephrine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8858 | ||||
| Human Metabolome Database | HMDB0014328 | ||||
| DrugBank | DB00182 | ||||
| PubChem: Thomson Pharma | 15297279 | ||||
| PubChem | 3007 | ||||
| Mcule | MCULE-4193952437 | ||||
| NMRShiftDB | 60027262 | ||||
| Nikkaji | J28.384C | ||||
| BindingDB | 50005246 | ||||
| EPA CompTox Dashboard | DTXSID4022600 | ||||
| DrugCentral | 195 | ||||
| Brenda | 39740 | 23090 | 5131 | ||
| Guide to Pharmacology | 4804 | ||||
| rxnorm | AMPHETAMINE SULFATE | AMPHETAMINE ASPARTATE | DYANAVEL | AMPHETAMINE | EVEKEO |
| KEGG Ligand | C07514 | ||||
| ChEBI | 132233 |
